Literature DB >> 20594620

Amyloid β1-42 oligomer inhibits myelin sheet formation in vitro.

Makoto Horiuchi1, Izumi Maezawa, Aki Itoh, Kouji Wakayama, Lee-Way Jin, Takayuki Itoh, Charles Decarli.   

Abstract

Accumulating evidence indicates that white matter degeneration contributes to the neural disconnections that underlie Alzheimer's disease pathophysiology. Although this white matter degeneration is partly attributable to axonopathy associated with neuronal degeneration, amyloid β (Aβ) protein-mediated damage to oligodendrocytes could be another mechanism. To test this hypothesis, we studied effects of soluble Aβ in oligomeric form on survival and differentiation of cells of the oligodendroglial lineage using highly purified oligodendroglial cultures from rats at different developmental stages. Aβ oligomer at 10 μM or higher reduced survival of mature oligodendrocytes, whereas oligodendroglial progenitor cells (OPCs) were relatively resistant to the Aβ oligomer-mediated cytotoxicity. Further study revealed that Aβ oligomer even at 1 μM accelerated 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) formazan exocytosis in mature oligodendrocytes, and, more significantly, inhibited myelin sheet formation after induction of in vitro differentiation of OPCs. These results imply a novel pathogenetic mechanism underlying Aβ oligomer-mediated white matter degeneration, which could impair myelin maintenance and remyelination by adult OPCs, resulting in accumulating damage to myelinating axons thereby contributing to neural disconnections.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20594620      PMCID: PMC3013291          DOI: 10.1016/j.neurobiolaging.2010.05.007

Source DB:  PubMed          Journal:  Neurobiol Aging        ISSN: 0197-4580            Impact factor:   4.673


  55 in total

1.  White matter lesions on magnetic resonance imaging in dementia with Lewy bodies, Alzheimer's disease, vascular dementia, and normal aging.

Authors:  R Barber; P Scheltens; A Gholkar; C Ballard; I McKeith; P Ince; R Perry; J O'Brien
Journal:  J Neurol Neurosurg Psychiatry       Date:  1999-07       Impact factor: 10.154

2.  Axonopathy and transport deficits early in the pathogenesis of Alzheimer's disease.

Authors:  Gorazd B Stokin; Concepción Lillo; Tomás L Falzone; Richard G Brusch; Edward Rockenstein; Stephanie L Mount; Rema Raman; Peter Davies; Eliezer Masliah; David S Williams; Lawrence S B Goldstein
Journal:  Science       Date:  2005-02-25       Impact factor: 47.728

3.  Biochemical and morphologic evidence of the interaction of oligodendrocyte membrane rafts with actin filaments.

Authors:  Katsutoshi Taguchi; Koji Yoshinaka; Ken-Ichi Yoshino; Kazuyoshi Yonezawa; Shohei Maekawa
Journal:  J Neurosci Res       Date:  2005-07-15       Impact factor: 4.164

Review 4.  NG2-expressing cells as oligodendrocyte progenitors in the normal and demyelinated adult central nervous system.

Authors:  Annabella Polito; Richard Reynolds
Journal:  J Anat       Date:  2005-12       Impact factor: 2.610

5.  Role of p21-activated kinase pathway defects in the cognitive deficits of Alzheimer disease.

Authors:  Lixia Zhao; Qiu-Lan Ma; Frédéric Calon; Marni E Harris-White; Fusheng Yang; Giselle P Lim; Takashi Morihara; Oliver J Ubeda; Surendra Ambegaokar; James E Hansen; Richard H Weisbart; Bruce Teter; Sally A Frautschy; Greg M Cole
Journal:  Nat Neurosci       Date:  2006-01-15       Impact factor: 24.884

6.  Diffusible, nonfibrillar ligands derived from Abeta1-42 are potent central nervous system neurotoxins.

Authors:  M P Lambert; A K Barlow; B A Chromy; C Edwards; R Freed; M Liosatos; T E Morgan; I Rozovsky; B Trommer; K L Viola; P Wals; C Zhang; C E Finch; G A Krafft; W L Klein
Journal:  Proc Natl Acad Sci U S A       Date:  1998-05-26       Impact factor: 11.205

7.  Detection of age-dependent brain injury in a mouse model of brain amyloidosis associated with Alzheimer's disease using magnetic resonance diffusion tensor imaging.

Authors:  Shu-Wei Sun; Sheng-Kwei Song; Michael P Harms; Shiow-Jiuan Lin; David M Holtzman; Kalpana M Merchant; John J Kotyk
Journal:  Exp Neurol       Date:  2005-01       Impact factor: 5.330

8.  Amyloid-beta peptide enhances tumor necrosis factor-alpha-induced iNOS through neutral sphingomyelinase/ceramide pathway in oligodendrocytes.

Authors:  C Zeng; J T Lee; H Chen; S Chen; C Y Hsu; J Xu
Journal:  J Neurochem       Date:  2005-08       Impact factor: 5.372

9.  Amyloid beta peptide alters intracellular vesicle trafficking and cholesterol homeostasis.

Authors:  Y Liu; D A Peterson; D Schubert
Journal:  Proc Natl Acad Sci U S A       Date:  1998-10-27       Impact factor: 11.205

10.  Amyloid beta peptide increases DP5 expression via activation of neutral sphingomyelinase and JNK in oligodendrocytes.

Authors:  Shawei Chen; Jin-Moo Lee; Chenbo Zeng; Hong Chen; Chung Y Hsu; Jan Xu
Journal:  J Neurochem       Date:  2006-03-08       Impact factor: 5.372

View more
  25 in total

1.  Cerebrovascular disease, β-amyloid, and cognition in aging.

Authors:  Natalie L Marchant; Bruce R Reed; Charles S DeCarli; Cindee M Madison; Michael W Weiner; Helena C Chui; William J Jagust
Journal:  Neurobiol Aging       Date:  2011-11-01       Impact factor: 4.673

2.  Single-particle characterization of Aβ oligomers in solution.

Authors:  Erik C Yusko; Panchika Prangkio; David Sept; Ryan C Rollings; Jiali Li; Michael Mayer
Journal:  ACS Nano       Date:  2012-06-21       Impact factor: 15.881

3.  Distinct White Matter Changes Associated with Cerebrospinal Fluid Amyloid-β1-42 and Hypertension.

Authors:  Omar M Al-Janabi; Christopher A Brown; Ahmed A Bahrani; Erin L Abner; Justin M Barber; Brian T Gold; Larry B Goldstein; Ronan R Murphy; Peter T Nelson; Nathan F Johnson; Leslie M Shaw; Charles D Smith; John Q Trojanowski; Donna M Wilcock; Gregory A Jicha
Journal:  J Alzheimers Dis       Date:  2018       Impact factor: 4.472

4.  Purified high molecular weight synthetic Aβ(1-42) and biological Aβ oligomers are equipotent in rapidly inducing MTT formazan exocytosis.

Authors:  Adam M Weidner; Molly Housley; M Paul Murphy; Harry Levine
Journal:  Neurosci Lett       Date:  2011-04-09       Impact factor: 3.046

5.  Distinct patterns of default mode and executive control network circuitry contribute to present and future executive function in older adults.

Authors:  Christopher A Brown; Frederick A Schmitt; Charles D Smith; Brian T Gold
Journal:  Neuroimage       Date:  2019-04-04       Impact factor: 6.556

6.  Co-Ultramicronized Palmitoylethanolamide/Luteolin Restores Oligodendrocyte Homeostasis via Peroxisome Proliferator-Activated Receptor-α in an In Vitro Model of Alzheimer's Disease.

Authors:  Roberta Facchinetti; Marta Valenza; Chiara Gomiero; Giulia Federica Mancini; Luca Steardo; Patrizia Campolongo; Caterina Scuderi
Journal:  Biomedicines       Date:  2022-05-26

7.  Differing intrinsic biological properties between forebrain and spinal oligodendroglial lineage cells.

Authors:  Makoto Horiuchi; Yoko Suzuki-Horiuchi; Tasuku Akiyama; Aki Itoh; David Pleasure; Earl Carstens; Takayuki Itoh
Journal:  J Neurochem       Date:  2017-06-09       Impact factor: 5.372

8.  Age and Alzheimer's pathology disrupt default mode network functioning via alterations in white matter microstructure but not hyperintensities.

Authors:  Christopher A Brown; Yang Jiang; Charles D Smith; Brian T Gold
Journal:  Cortex       Date:  2018-04-19       Impact factor: 4.027

9.  Cognitive profile of amyloid burden and white matter hyperintensities in cognitively normal older adults.

Authors:  Trey Hedden; Elizabeth C Mormino; Rebecca E Amariglio; Alayna P Younger; Aaron P Schultz; J Alex Becker; Randy L Buckner; Keith A Johnson; Reisa A Sperling; Dorene M Rentz
Journal:  J Neurosci       Date:  2012-11-14       Impact factor: 6.167

10.  Failure to modulate attentional control in advanced aging linked to white matter pathology.

Authors:  Trey Hedden; Koene R A Van Dijk; Emily H Shire; Reisa A Sperling; Keith A Johnson; Randy L Buckner
Journal:  Cereb Cortex       Date:  2011-07-17       Impact factor: 5.357

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.